Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
A separate analysis of patients with both obesity and a prior AUD diagnosis showed even more dramatic results those on GLP-1 agonists were significantly less likely to experience AUD recurrence
The most commonly reported side effects are gastrointestinal complaints such as abdominal pain, bloating and diarrhoea
Frequently Asked Questions Will my BCBS plan cover Wegovy if I have a BMI over 30
as GLP-1 RA prescribing grows
US$ 28.64
US$ 28.77
US$ 26.70
